Here’s our take on autism circa 2026: 

The new AACAP policy is revolutionary. It changes the standard of care to include strength-based developmental relationship-based interventions (DRBI) and naturalistic developmental-behavioral interventions (NDBI). Informed consent demands that providers inform families of these approaches, and policymakers need to cover them. Expanded options and access mean better and more efficient care. Learn more: www.tinyurl.com/4kwd4zux

The state of autism today? DEI is in federal drought, while neuro-affirming health care, education, and occupational accommodations blossom (www.tinyurl.com/yhrmh3vs). Benefits of vaccines far outweigh risks. Autism is “increasing” because we see it better (Eicher T et al, N Engl J Med 2026;394:313–315). Leucovorin needs research. It might help selected patients, and it’s probably harmless, but we need more data. The latest meta-analysis shows no autism risk for acetaminophen. If anything, acetaminophen is protective, not harmful, in pregnancy, as reducing fever reduces autism risk (Blencowe H et al, Lancet Obstet Gynaecol Women’s Health 2026; Epub ahead of print).

Most of our autistic patients become involved with legal systems (see our table on page 5 of this issue) and have more potential than we’ve thought (see our interview with Dr. Baker-Ericzen on page 6). All of them need suicide screening (see our feature article on page 1). As always, there’s more in this issue. 

Joshua D. Feder, MD

jfeder@thecarlatreport.com